학술논문

A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion.
Document Type
journal article
Source
British Journal of Cancer; Nov1998, Vol. 78 Issue 10, p1329-1336, 8p
Subject
Language
ISSN
00070920